Eurofins Scientific Nante (ERFSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 7,521,677 | 7,050,751 | 7,071,869 | 7,947,711 | 6,212,741 |
| Cost of Goods | 5,964,103 | 5,714,760 | 5,580,919 | 5,770,807 | 4,669,608 |
| Gross Profit | 1,557,575 | 1,335,991 | 1,490,949 | 2,176,904 | 1,543,019 |
| Operating Expenses | 769,475 | 736,616 | 673,433 | 686,768 | 626,360 |
| Operating Income | 788,202 | 600,135 | 818,436 | 1,490,943 | 917,381 |
| Interest Expense | 189,800 | 165,159 | 148,979 | 245,730 | 129,194 |
| Other Income | 1,731 | 23,161 | 152,351 | 4,850 | 5,026 |
| Pre-tax Income | 600,133 | 458,138 | 821,808 | 1,250,063 | 793,213 |
| Income Tax | 161,341 | 125,006 | 183,537 | 323,696 | 175,800 |
| Net Income Continuous | 438,792 | 333,132 | 638,271 | 926,367 | 617,413 |
| Minority Interests | -974 | -2,706 | -4,636 | 473 | 1,142 |
| Net Income | $439,765 | $335,838 | $642,907 | $925,894 | $616,271 |
| EPS Basic Total Ops | 2.31 | 1.74 | 3.34 | 4.84 | 3.31 |
| EPS Basic Continuous Ops | 2.30 | 1.73 | 3.32 | 4.84 | 3.32 |
| EPS Diluted Total Ops | 2.26 | 1.70 | 3.23 | 4.61 | 3.14 |
| EPS Diluted Continuous Ops | 2.26 | 1.68 | 3.21 | 4.62 | 3.15 |
| EPS Diluted Before Non-Recurring Items | 3.65 | 2.89 | 3.64 | 5.96 | 3.95 |
| EBITDA(a) | $1,460,294 | $1,236,311 | $1,352,190 | $2,026,532 | $1,407,085 |